메뉴 건너뛰기




Volumn 4, Issue 1, 2011, Pages 81-88

Matrix metalloproteinase-2 as a marker of microvascular complications in children and adolescents with type I diabetes mellitus

Author keywords

Matrix metalloproteinase 2; Microvascular complications; Type I diabetes

Indexed keywords

GELATINASE A; HEMOGLOBIN A1C;

EID: 79953125660     PISSN: 18575749     EISSN: 18575773     Source Type: Journal    
DOI: 10.3889/MJMS.1857-5773.2011.0151     Document Type: Article
Times cited : (2)

References (33)
  • 2
    • 0034913347 scopus 로고    scopus 로고
    • Elevated matrix metalloproteinase-2 and-9 in urine, but not in serum, are markers of type 1 diabetic nephropathy
    • Diamant M, Hanemaaijer R, Verheijen JH.et al. Elevated matrix metalloproteinase-2 and-9 in urine, but not in serum, are markers of type 1 diabetic nephropathy. Diabetes Med. 2001;18:423-424.
    • (2001) Diabetes Med , vol.18 , pp. 423-424
    • Diamant, M.1    Hanemaaijer, R.2    Verheijen, J.H.3
  • 3
    • 0035229441 scopus 로고    scopus 로고
    • Immunohistochemistry of MMPs and TIMPs
    • Okada Y. Immunohistochemistry of MMPs and TIMPs.Methods Mol Biol. 2001;151:359-65.
    • (2001) Methods Mol Biol , vol.151 , pp. 359-365
    • Okada, Y.1
  • 4
    • 0033780333 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension
    • Relationship to left ventricular mass and anti-hypertensive therapy
    • Li-Saw-Hee FL, Edmunds E, Blann A, Beevers DG, Lip GY. Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol. 2000;75:43-47.
    • (2000) Int J Cardiol , vol.75 , pp. 43-47
    • Li-Saw-Hee, F.L.1    Edmunds, E.2    Blann, A.3    Beevers, D.G.4    Lip, G.Y.5
  • 5
    • 0037693895 scopus 로고    scopus 로고
    • Matrix metalloproteinases and tissueinhibitors of metalloproteinases: Structure, function, andbiochemistry
    • Visse R and Nagase H. Matrix metalloproteinases and tissueinhibitors of metalloproteinases: structure, function, andbiochemistry. Circ Res. 2003;92:827-839.
    • (2003) Circ Res , vol.92 , pp. 827-839
    • Visse, R.1    Nagase, H.2
  • 6
    • 0032769379 scopus 로고    scopus 로고
    • Cellular mechanisms of diabetic vascular hypertrophy
    • Vranes D, Cooper ME, Dilley RJ. Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res. 1999;57(1):8-18.
    • (1999) Microvasc Res , vol.57 , Issue.1 , pp. 8-18
    • Vranes, D.1    Cooper, M.E.2    Dilley, R.J.3
  • 7
    • 0037407721 scopus 로고    scopus 로고
    • Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy
    • Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2003;44(5):2163-70.
    • (2003) Invest Ophthalmol Vis Sci , vol.44 , Issue.5 , pp. 2163-2170
    • Noda, K.1    Ishida, S.2    Inoue, M.3    Obata, K.4    Oguchi, Y.5    Okada, Y.6    Ikeda, E.7
  • 8
    • 0034786386 scopus 로고    scopus 로고
    • Peripheral blood level alterations of 1TIMP-1 MMP-2 and MMP- 9 in patients with type 1 diabetes
    • Maxwell PR, Timmes PM, Chandran S, Gordon D. Peripheral blood level alterations of 1TIMP-1 MMP-2 and MMP- 9 in patients with type 1 diabetes. Diabetes Med. 2001;18: 777-780.
    • (2001) Diabetes Med , vol.18 , pp. 777-780
    • Maxwell, P.R.1    Timmes, P.M.2    Chandran, S.3    Gordon, D.4
  • 9
    • 0037324289 scopus 로고    scopus 로고
    • Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease
    • Marx N, Froehlich J, Siam L, et al. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2003;23:283-288.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 283-288
    • Marx, N.1    Froehlich, J.2    Siam, L.3
  • 10
    • 0032849144 scopus 로고    scopus 로고
    • Competitive RT-PCR for measuring metalloproteinase gene expression in human mesangial cells exposed to a hyperglycemic environment
    • Death AK, Yue DK, Turtle JR. Competitive RT-PCR for measuring metalloproteinase gene expression in human mesangial cells exposed to a hyperglycemic environment. Biotechniques. 1999;27:512-518.
    • (1999) Biotechniques , vol.27 , pp. 512-518
    • Death, A.K.1    Yue, D.K.2    Turtle, J.R.3
  • 11
    • 79953116450 scopus 로고    scopus 로고
    • Cairo University, In collaboration with Wright State University. School of Medicine, Department of Community Health Lifespan. Health Research Center. From a Total Sample Size of 33189 Girls and Boys Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center
    • Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center. Cairo University, In collaboration with Wright State University. School of Medicine. Department of Community Health lifespan. Health Research Center. From a total sample size of 33189 girls and boys. Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center, 2003.
    • (2003) Diabetic Endocrine and Metabolic Pediatric Unit and the National Research Center
  • 12
    • 75149130955 scopus 로고    scopus 로고
    • Diagnosis and Classification of Diabetes Mellitus
    • American Diabetes Association (ADA)
    • American Diabetes Association (ADA). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010; 33(1):562-569.
    • (2010) Diabetes Care , vol.33 , Issue.1 , pp. 562-569
  • 14
    • 0027534228 scopus 로고
    • A new international reference preparation for proteins in human serum
    • Johnson AM. A new international reference preparation for proteins in human serum. Arch Pathol Med. 1993;117:19-31.
    • (1993) Arch Pathol Med , vol.117 , pp. 19-31
    • Johnson, A.M.1
  • 15
    • 0036240803 scopus 로고    scopus 로고
    • Screening for vascular complications in children and adolescents with type 1 diabetes mellitus
    • Chiarelli F, Mohn A, Tumini S, Trotta D, Verrotti A. Screening for vascular complications in children and adolescents with type 1 diabetes mellitus. Horm Res. 2002;57(Suppl 1):113-6.
    • (2002) Horm Res , vol.57 , Issue.SUPPL. 1 , pp. 113-116
    • Chiarelli, F.1    Mohn, A.2    Tumini, S.3    Trotta, D.4    Verrotti, A.5
  • 16
    • 33846000986 scopus 로고    scopus 로고
    • Increased circulatory MMP- 2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus
    • Shiau MY, Tsai ST, Tsai KJ et al. Increased circulatory MMP- 2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med. 2006; 73(7):1024-8.
    • (2006) Mt Sinai J Med , vol.73 , Issue.7 , pp. 1024-1028
    • Shiau, M.Y.1    Tsai, S.T.2    Tsai, K.J.3
  • 17
    • 34548435665 scopus 로고    scopus 로고
    • Matrix metalloproteinase-2 dysregulation in type 1 diabetes
    • Thrailkill KM, Bunn RC, Moreau CS et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care. 2007;30(9):2321-6.
    • (2007) Diabetes Care , vol.30 , Issue.9 , pp. 2321-2326
    • Thrailkill, K.M.1    Bunn, R.C.2    Moreau, C.S.3
  • 18
    • 1042291851 scopus 로고    scopus 로고
    • Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes
    • Derosa G, Avanzini MA, Geroldi D et al. Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes. Diabetes Care. 2005;27(1):273-274.
    • (2005) Diabetes Care , vol.27 , Issue.1 , pp. 273-274
    • Derosa, G.1    Avanzini, M.A.2    Geroldi, D.3
  • 20
    • 33747611521 scopus 로고    scopus 로고
    • Reduced expression of vascular endothelial growth factor paralleled with theincreased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and-9 in human type 2 diabetic arterial vasculature
    • Chung AW, Hsiang YN, Matzke LA et al. Reduced expression of vascular endothelial growth factor paralleled with theincreased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and-9 in human type 2 diabetic arterial vasculature. Circ Res. 2006; 99:140-148.
    • (2006) Circ Res , vol.99 , pp. 140-148
    • Chung, A.W.1    Hsiang, Y.N.2    Matzke, L.A.3
  • 21
    • 0038173265 scopus 로고    scopus 로고
    • High glucose alters matrix metalloproteinase expression in two key vascular cells: Potential impact on atherosclerosis in diabetes
    • Death AK, Fisher EJ, McGrath KC, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis. 2003;168:263-269.
    • (2003) Atherosclerosis , vol.168 , pp. 263-269
    • Death, A.K.1    Fisher, E.J.2    McGrath, K.C.3    Yue, D.K.4
  • 22
    • 0038170437 scopus 로고    scopus 로고
    • High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells
    • Hao F, Yu JD. High glucose enhance expression of matrix metalloproteinase-2 in smooth muscle cells. Acta PharmacoSin. 2003;24:534-538.
    • (2003) Acta PharmacoSin , vol.24 , pp. 534-538
    • Hao, F.1    Yu, J.D.2
  • 24
    • 0036190236 scopus 로고    scopus 로고
    • Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
    • Bangstad HJ, Osterby R, Rudberg S. et al. Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria. Diabetologia. 2002;45(2):253-261.
    • (2002) Diabetologia , vol.45 , Issue.2 , pp. 253-261
    • Bangstad, H.J.1    Osterby, R.2    Rudberg, S.3
  • 25
    • 0035988186 scopus 로고    scopus 로고
    • Structural changes in renal arterioles in Type 1diabetic patients
    • Osterby R, Hartmann A, Bangstad HJ. Structural changes in renal arterioles in Type 1diabetic patients. Diabetologia. 2002;45(4):542-549.
    • (2002) Diabetologia , vol.45 , Issue.4 , pp. 542-549
    • Osterby, R.1    Hartmann, A.2    Bangstad, H.J.3
  • 26
    • 33645456579 scopus 로고    scopus 로고
    • Therapeutic potential of angiostatin in diabetic nephropathy
    • Zhang SX, Wang JJ, Lu K et al. Therapeutic potential of angiostatin in diabetic nephropathy. J Am Soc Nephrol. 2006;17:475-486.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 475-486
    • Zhang, S.X.1    Wang, J.J.2    Lu, K.3
  • 27
    • 33744474294 scopus 로고    scopus 로고
    • Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats
    • Sun SZ, Wang Y, Li Q. et al. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Chin Med J (Engl). 2006;119:814-821.
    • (2006) Chin Med J (Engl) , vol.119 , pp. 814-821
    • Sun, S.Z.1    Wang, Y.2    Li, Q.3
  • 28
    • 25144442812 scopus 로고    scopus 로고
    • Establishment of a diabetic mouse model with progressive diabetic nephropathy
    • Inada A, Nagai K, Arai H et al. Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am JPathol. 2005;167:327-336.
    • (2005) Am JPathol , vol.167 , pp. 327-336
    • Inada, A.1    Nagai, K.2    Arai, H.3
  • 29
    • 0034943382 scopus 로고    scopus 로고
    • High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1
    • Singh R, Song RH, Alavi N et al. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol. 2001;9:249-257.
    • (2001) Exp Nephrol , vol.9 , pp. 249-257
    • Singh, R.1    Song, R.H.2    Alavi, N.3
  • 30
    • 0034880505 scopus 로고    scopus 로고
    • Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients
    • Romanic AM, Burns-Kurtis CL, Ao Z, Arleth AJ, Ohlstein EH. Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients. Am J Physio. 2001;281:F309-F317.
    • (2001) Am J Physio , vol.281
    • Romanic, A.M.1    Burns-Kurtis, C.L.2    Ao, Z.3    Arleth, A.J.4    Ohlstein, E.H.5
  • 31
    • 79953108737 scopus 로고    scopus 로고
    • New Developments in Retinopathy
    • Posted: 12/16/2004; Updated: 12/21/2004
    • Hammes, HP. New Developments in Retinopathy. Medscape Diabetes & Endocrinology, 2004. Posted: 12/16/2004; Updated: 12/21/2004.
    • (2004) Medscape Diabetes & Endocrinology
    • Hammes, H.P.1
  • 32
    • 18744362465 scopus 로고    scopus 로고
    • Matrix metalloproteinases in early diabetic retinopathy and their rolein alteration of the blood-retinal barrier
    • Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their rolein alteration of the blood-retinal barrier. Lab Invest. 2005;85: 597-607.
    • (2005) Lab Invest , vol.85 , pp. 597-607
    • Giebel, S.J.1    Menicucci, G.2    McGuire, P.G.3    Das, A.4
  • 33
    • 0033810812 scopus 로고    scopus 로고
    • Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy
    • Salzmann Jm, Limb GA, Khaw PT et al. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol. 2000;84:1091-1096.
    • (2000) Br J Ophthalmol , vol.84 , pp. 1091-1096
    • Salzmann, J.M.1    Limb, G.A.2    Khaw, P.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.